Clinical Trial Update: A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes that a randomized, controlled pilot study of Mesalazine in Irritable bowel syndrome has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: SOFAR S.p.A. | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: COMPLETED